The Role of (18)F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Predicting Pathologic Response After Induction Therapy for Thymic Epithelial Tumors.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28265732)

Published in World J Surg on March 06, 2017

Authors

Koichi Fukumoto1, Takayuki Fukui2, Toshiki Okasaka2, Koji Kawaguchi2, Shota Nakamura2, Shuhei Hakiri2, Naoki Ozeki2, Tomoshi Sugiyama2, Katsuhiko Kato3, Kohei Yokoi2

Author Affiliations

1: Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. kfukumoto@med.nagoya-u.ac.jp.
2: Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
3: Department of Radiological and Medical Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles cited by this

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (2009) 77.71

Preoperative staging of lung cancer with combined PET-CT. N Engl J Med (2009) 7.38

Follow-up study of thymomas with special reference to their clinical stages. Cancer (1981) 5.75

The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours. Eur J Cardiothorac Surg (2012) 2.12

Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma. JAMA Surg (2015) 1.50

Thoracic and cardiovascular surgery in Japan during 2013 : Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2015) 1.33

Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms. Lung Cancer (2011) 1.31

Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer. Ann Thorac Surg (2004) 1.30

Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol (2007) 1.10

Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer. J Nucl Med (2015) 1.06

Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in predicting the pathologic response to preoperative chemoradiation therapy in patients with resectable T3 pancreatic cancer. World J Surg (2013) 1.01

Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value. Eur J Cardiothorac Surg (2011) 0.89

Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS One (2016) 0.89

18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors. Ann Nucl Med (2010) 0.89

Value of (18)F-FDG PET for Predicting Response to Neoadjuvant Therapy in Rectal Cancer: Systematic Review and Meta-Analysis. AJR Am J Roentgenol (2015) 0.88

Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis. Lung Cancer (2014) 0.86

18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors. Clin Cancer Res (2013) 0.84

Response evaluation in mesothelioma: Beyond RECIST. Lung Cancer (2015) 0.81

Which variables should be considered in patients with stage II and III non-small cell lung cancer after neoadjuvant therapy? Nagoya J Med Sci (2015) 0.78

Articles by these authors

The tumor doubling time is a useful parameter for predicting the histological type of thymic epithelial tumors. Surg Today (2019) 1.38

The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer. PLoS One (2015) 1.03

Growth rate of chemotherapy-naïve lung metastasis from colorectal cancer could be a predictor of early relapse after lung resection. Int J Clin Oncol (2015) 0.77

The development of large-cell carcinoma in the wall of a giant bulla complicated by hemorrhage. Surg Case Rep (2016) 0.75

Pulmonary metastasis from urothelial carcinoma of the upper urinary tract 29 years after nephrectomy. Surg Case Rep (2017) 0.75

Evaluation of locoregional invasiveness of small-sized non-small cell lung cancers by enhanced dual-energy computed tomography. Cancer Imaging (2016) 0.75

Risk Assessment for Loss-of-Exercise Capacity After Lung Cancer Surgery: Current Advances in Surgery and Systemic Treatment. World J Surg (2022) 0.75

Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer. Gen Thorac Cardiovasc Surg (2017) 0.75

Nontuberculous mycobacterial disease concomitant with a pulmonary artery occlusion caused by Takayasu's arteritis. Gen Thorac Cardiovasc Surg (2016) 0.75

A survival analysis using physique-adjusted tumor size of non-small cell lung cancer. Int J Clin Oncol (2017) 0.75

Left ventricular phase entropy: Novel prognostic predictor in patients with dilated cardiomyopathy and narrow QRS. J Nucl Cardiol (2017) 0.75

A bilateral approach to extended thymectomy using the da Vinci Surgical System for patients with myasthenia gravis. Surg Today (2017) 0.75

Extralobar pulmonary sequestration in the middle mediastinum. Gen Thorac Cardiovasc Surg (2016) 0.75

Development of a prototype Open-close positron emission tomography system. Rev Sci Instrum (2015) 0.75

Collaborative operation with cardiovascular surgeons in general thoracic surgery. Gen Thorac Cardiovasc Surg (2017) 0.75

Neuroanatomical correlates of error types on the Clock Drawing Test in Alzheimer's disease patients. Geriatr Gerontol Int (2015) 0.75